Latest KFF Health News Stories
Five Years Later, HIV-Hit Town Rebounds. But The Nation Is Slow To Heed Lessons.
In February 2015, an unprecedented HIV outbreak fueled by intravenous drug use hit the small city of Austin, Indiana. Under pressure, then-Gov. Mike Pence reluctantly allowed a syringe exchange. Five years later, HIV is undetectable in most of the outbreak patients. Still, the lessons haven’t been learned nationwide. Fewer than a third of the 220 counties deemed by the federal government as vulnerable to similar outbreaks have active syringe-exchange programs.
Para combatir el COVID-19, usan drogas contra el VIH, la malaria y el Ébola
Cuando surge un nuevo virus y pone en peligro a un gran número de personas, los científicos a veces recurren a medicamentos ya existentes que pueden readaptarse.
To Fight Chinese Outbreak, Doctors Deploy Drugs Targeting HIV, Malaria And Ebola
Chinese doctors and public health officials are turning to a variety of drugs as they seek an effective treatment for patients sickened by the novel coronavirus. The evidence behind some of these medicines is flimsy, researchers acknowledge, but human trials are the only way to know whether these drugs work.
Conservative Indiana Adopted Needle Exchanges But Still Faces Local Resistance
Indiana was ground zero for shifting ideas about needle exchanges after a small town had an HIV outbreak in 2015 brought on by needle-sharing. But even as other parts of the country start to embrace needle exchanges amid the ongoing opioid epidemic, the sites remain controversial in Indiana. Only nine of the state’s 92 counties have them, after a series of closures and reopenings.
Listen: The Cost Of PrEP, The HIV Prevention Pill
KHN correspondent Shefali Luthra was among the guests on the podcast “Today, Explained” to talk about PrEP.
El gobierno dará medicamentos para prevenir el VIH gratis. ¿Calificas?
La administración Trump lanza plan para ofrecer gratis medicamentos preventivos contra el VIH a las personas que no tienen seguro de salud.
HHS Hands Out Free HIV Prevention Drugs. Do You Qualify?
Called “Ready, Set, PrEP,” the federal program will provide medication that can reduce the chances of getting AIDS to at-risk patients who don’t have insurance.
New California Law May Expand Use Of HIV Prevention Drugs, With Caveats
Legislation that takes effect next July will let people buy the medications without a prescription for a limited period. Medical professionals say it’s a step in the right direction but will not significantly increase the use of the medicine without additional efforts.
KHN’s ‘What The Health’: Spending Bill Slowdown
It’s November, do you know where your HHS spending bill is? Still stuck in Congress. Meanwhile, lawmakers move ahead on restricting tobacco products for youth while the administration’s proposal is MIA. Rebecca Adams of CQ Roll Call and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss this and more health news from the week. Also, Rovner interviews Dan Weissmann, host of the podcast “An Arm and a Leg.”
Listen: HHS Files Challenge Over Rights To Gilead’s HIV-Prevention Drug
KHN’s Shefali Luthra discusses the recent Trump administration lawsuit regarding the HIV-prevention drug Truvada.
Gobernador de California firma larga lista de leyes de salud que revelan los problemas de 2020
El Gobernador Gavin Newsom terminó su maratón de firmas, poniendo fin a una sesión legislativa que tendrá un impacto enorme en la atención de salud y la cobertura de los californianos.
California Governor’s Bill-Signing Marathon Offers Glimpse Of 2020 Issues
California Gov. Gavin Newsom signed off on an array of health care bills that will significantly affect the lives of Californians, including many college students, pregnant women, schoolchildren and dialysis patients.
New Protocol For HIV Prevention Drug Reduces The Number Of Pills Required
Health officials and AIDS advocates in San Francisco have endorsed a new regimen for PrEP medication: to be taken only immediately before and after sex, thus reducing cost and potential side effects. The standard regimen is one pill a day for an open-ended period.
Costos adicionales bloquean el tratamiento para prevenir el VIH
Aunque muchas aseguradoras cubren PrEP, los costos por las pruebas adicionales que hay que realizarse pueden bloquear el acceso a esta terapia preventiva.
Even When HIV Prevention Drug Is Covered, Other Costs Block Treatment
The U.S. Preventive Services Task Force recommended that people who are at high risk of contracting HIV take PrEP, a preventive treatment. The decision means most health plans will be required to cover the drugs without charging patients. But the recommendation doesn’t apply to the other clinical and lab services people need.
Florida es el último estado republicano en adoptar programa de intercambio de jeringas
Un programa piloto en el condado de Miami-Dade demostró la efectividad de esta intervención de salud pública. Una nueva ley podría ampliarla a otros condados.
Florida Is The Latest Republican-Led State To Adopt Clean Needle Exchanges
Florida has struggled for years with opioid overdoses — and the highest rate of HIV infection in the U.S. Lawmakers now hope needle exchanges and a “harm reduction” approach could help save lives.
Needle Exchanges Find New Champions Among Republicans
More Republicans, at the statehouse level, are saying research and results support their endorsement of a once-controversial plan to limit disease among drug users.
Nation’s First HIV-To-HIV Kidney Transplant With Living Donor Succeeds
The organ transplant from a living donor opens up the universe of available organs.
Podcast: KHN’s ‘What The Health?’ Surprise! Fixing Surprise Medical Bills Is Harder Than it Looks
Joanne Kenen of Politico, Anna Edney of Bloomberg News and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss the efforts to curb “surprise” medical bills to patients who inadvertently get out-of-network care; a look at where the 2020 presidential candidates stand on health; and the Trump administration’s efforts to end HIV in the U.S. Also, Rovner interviews Food and Drug Administration Commissioner Scott Gottlieb, who is leaving his job in early April.
